Spring 2016 FDA Guidance Core Series on INDs

All investigators are invited to bring their staff to discuss the UHCMC process for obtaining an investigator held Investigational New Drug (IND) Application. See attached flyer for course information.

Tuesdays, 1/26/16-3/1/16
9-10am
Wolstein Research Building 1403

View Flyer